AU2194895A - Composition and methods for creating syngeneic recombinant virus-producing cells - Google Patents

Composition and methods for creating syngeneic recombinant virus-producing cells

Info

Publication number
AU2194895A
AU2194895A AU21948/95A AU2194895A AU2194895A AU 2194895 A AU2194895 A AU 2194895A AU 21948/95 A AU21948/95 A AU 21948/95A AU 2194895 A AU2194895 A AU 2194895A AU 2194895 A AU2194895 A AU 2194895A
Authority
AU
Australia
Prior art keywords
syngeneic
creating
composition
methods
producing cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21948/95A
Inventor
David T Curiel
Robert I. Garver Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alabama at Birmingham Research Foundation
Original Assignee
University of Alabama at Birmingham Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US21821794A priority Critical
Priority to US218217 priority
Application filed by University of Alabama at Birmingham Research Foundation filed Critical University of Alabama at Birmingham Research Foundation
Priority to PCT/US1995/003729 priority patent/WO1995026411A2/en
Publication of AU2194895A publication Critical patent/AU2194895A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361Methods of inactivation or attenuation
    • C12N2710/10362Methods of inactivation or attenuation by genetic engineering
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
AU21948/95A 1994-03-25 1995-03-24 Composition and methods for creating syngeneic recombinant virus-producing cells Abandoned AU2194895A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US21821794A true 1994-03-25 1994-03-25
US218217 1994-03-25
PCT/US1995/003729 WO1995026411A2 (en) 1994-03-25 1995-03-24 Composition and methods for creating syngeneic recombinant virus-producing cells

Publications (1)

Publication Number Publication Date
AU2194895A true AU2194895A (en) 1995-10-17

Family

ID=22814221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21948/95A Abandoned AU2194895A (en) 1994-03-25 1995-03-24 Composition and methods for creating syngeneic recombinant virus-producing cells

Country Status (2)

Country Link
AU (1) AU2194895A (en)
WO (1) WO1995026411A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1548118A2 (en) * 1994-06-10 2005-06-29 Genvec, Inc. Complementary adenoviral vector systems and cell lines
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
SI0833934T2 (en) 1995-06-15 2013-04-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
FR2741358B1 (en) * 1995-11-17 1998-01-02 Centre Nat Rech Scient Production of retroviral vectors by viral vectors intermediate to basic virus DNA
FR2747046B1 (en) * 1996-04-05 1998-06-19 Univ Paris Curie New vaccines from plasmovirus
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
ES2359625T3 (en) 2000-12-28 2011-05-25 Wyeth Llc Protective protein recombinant of.
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp Novel immunogenic compositions for the prevention and treatment of meningococcal disease.
US20030158112A1 (en) 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
US7648772B2 (en) * 2005-06-28 2010-01-19 International Paper Co. Moisture resistant container
AR064642A1 (en) 2006-12-22 2009-04-15 Wyeth Corp Polynucleotide vector that comprises recombinant cell comprising the vector polypeptide, antibody, composition comprising the polynucleotide, vector, polypeptide or antibody recombinant cell, using the composition and method for preparing the same composition and prepare a composi
CN102203122A (en) 2008-11-05 2011-09-28 惠氏有限责任公司 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
PT2608805T (en) 2010-08-23 2017-09-11 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
AU2013216920B2 (en) 2012-02-07 2016-09-22 Global Bio Therapeutics, Inc. Compartmentalized method of nucleic acid delivery and compositions and uses thereof
PE20142115A1 (en) 2012-03-09 2014-12-17 Pfizer Neisseria meningitidis compositions and methods thereof
US10196429B2 (en) 2012-03-09 2019-02-05 Pfizer Inc. Neisseria meningitidis composition and methods thereof
JP6446377B2 (en) 2013-03-08 2018-12-26 ファイザー・インク Immunogenic fusion polypeptide
EP2968613B1 (en) 2013-03-11 2019-09-11 University of Florida Research Foundation, Inc. Delivery of card protein as therapy for occular inflammation
WO2015033251A2 (en) 2013-09-08 2015-03-12 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
AU2018215585A1 (en) 2017-01-31 2019-07-18 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
WO1993019092A1 (en) * 1992-03-19 1993-09-30 Centre National De La Recherche Scientifique Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins

Also Published As

Publication number Publication date
WO1995026411A2 (en) 1995-10-05
WO1995026411A3 (en) 1996-07-18

Similar Documents

Publication Publication Date Title
AU694293B2 (en) Polyethylene composition
AU681240C (en) Macroencapsulated secretory cells
AU687231B2 (en) Supported ionic catalyst composition
AU690366B2 (en) Sunscreen-wound healing composition
AU688971B2 (en) An oxygen absorbing composition
AU689123B2 (en) Electrode and preparation thereof
AU640370B2 (en) Nonreplicable document and method for making same
AU687510B2 (en) Nucleic acid mutation detection in histologic tissue
AU2247699A (en) Cell control method and apparatus
AU1458395A (en) Composition containing nucleic acids, preparation and uses
AU9403698A (en) Sputter-deposited fuel cell membranes and electrodes
AU1818395A (en) Yeast strains and modified albumins
AU4155096A (en) Modified green fluorescenct proteins
AU6823096A (en) Stanol composition and the use thereof
AU4887893A (en) Fibrin sealant compositions and methods for utilizing same
AU1688695A (en) Adenoviral-mediated method of cell transfection
AU3263695A (en) Scanning arrangement and method
AU8239987A (en) Thrombin derived polypeptides; compositions and methods for use
AU5155498A (en) Polymorphisms in the glucose-6 phosphate dehydrogenase locus
AU5399898A (en) Method and compositions for weight control
AU4286396A (en) Plasma concentrate and tissue sealant compositions
HK1023950A1 (en) Gel composition and methods.
AU3332297A (en) Compounds and methods for modulating cell adhesion
AU1488295A (en) Pharmaceutical composition
AU5220098A (en) Compositions and methods for enhancing intestinal function